MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2352-3026(24)00067-x

Медицинская библиотека · The Lancet. Haematology · 2024

Methodological challenges in the development of endpoints for myelofibrosis clinical trials.

Barosi Giovanni, Tefferi Ayalew, Gangat Naseema, Szuber Natasha, Rambaldi Alessandro, Odenike Olatoyosi, Kröger Nicolaus, Gagelmann Nico, Talpaz Moshe, Kantarjian Hagop, Gale Robert Peter

СтатьяПеревод в очереди

Аннотация

Myelofibrosis is a myeloid neoplasm characterised by the presence of JAK2, CALR, or MPL mutations (with a 90% mutation frequency) and trilineage myeloid proliferation with prominent megakaryocyte atypia. People with myelofibrosis have a lower survival rate and poorer quality of life than healthy individuals. Therapy for myelofibrosis uses Janus kinase inhibitors, which reduce splenomegaly and alleviate symptoms. Regulatory approvals for Janus kinase inhibitors have focused on this dual endpoint. In this Viewpoint, we discuss the validity of using spleen reduction as a surrogate endpoint for the disease-modifying activity of candidate drugs for myelofibrosis. We suggest alternative endpoints addressing unmet patient needs, including progression-free survival and overall survival. Moreover, we highlight the importance of selecting a core set of crucial outcomes with which we can individualise clinical decision making and standardise reporting of clinical trials results. We propose selecting patient-reported outcomes and anaemia response. We also suggest integrating economic considerations in the process of evaluating new drugs for myelofibrosis.

Для цитирования: Barosi Giovanni, Tefferi Ayalew, Gangat Naseema, Szuber Natasha, Rambaldi Alessandro, Odenike Olatoyosi, Kröger Nicolaus, Gagelmann Nico, Talpaz Moshe, Kantarjian Hagop, Gale Robert Peter. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.. The Lancet. Haematology. 2024. DOI: 10.1016/s2352-3026(24)00067-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.